» Articles » PMID: 14499264

Nuclear War: the Granzyme A-bomb

Overview
Publisher Elsevier
Date 2003 Sep 23
PMID 14499264
Citations 40
Authors
Affiliations
Soon will be listed here.
Abstract

Granzyme A, a serine protease in the cytotoxic granules of natural killer cells and cytotoxic T lymphocytes, induces caspase-independent cell death when introduced into target cells by perforin. Granzyme A induces single-stranded DNA damage as well as rapid loss of cell membrane integrity and mitochondrial transmembrane potential through unknown mechanisms. Granzyme A destroys the nuclear envelope by targeting lamins and opens up DNA for degradation by targeting histones. A special target of the granzyme A cell death pathway is an endoplasmic reticulum-associated complex, called the SET complex, which contains three granzyme A substrates, the nucleosome assembly protein SET, the DNA bending protein HMG-2, and the base excision repair endonuclease Ape1. The SET complex also contains the tumor suppressor protein pp32 and the granzyme A-activated DNase NM23-H1, which is inhibited by SET. Granzyme A cleavage of SET releases the inhibition and unleashes NM23-H1. Cleavage of Ape1 by granzyme A interferes with the ability of the target cell to repair itself. The novel cell death pathway initiated by granzyme A provides a parallel pathway for apoptosis, important in destroying targets that overexpress bcl-2 or are otherwise invulnerable to the caspases.

Citing Articles

High-dimensional single-cell analysis of human natural killer cell heterogeneity.

Rebuffet L, Melsen J, Escaliere B, Basurto-Lozada D, Bhandoola A, Bjorkstrom N Nat Immunol. 2024; 25(8):1474-1488.

PMID: 38956378 PMC: 11291291. DOI: 10.1038/s41590-024-01883-0.


Targeted Therapy of Spinal Cord Injury: Inhibition of Apoptosis Is a Promising Therapeutic Strategy.

He W, Li Z, Gu H, Pan Q, Lin F Mol Neurobiol. 2023; 61(7):4222-4239.

PMID: 38066400 DOI: 10.1007/s12035-023-03814-w.


Modulating the tumor microenvironment improves antitumor effect of anti-PD-L1 mAb in breast cancer.

Li X, Luo X, Hu S Bioimpacts. 2023; 13(2):89-96.

PMID: 37193073 PMC: 10182444. DOI: 10.34172/bi.2023.24166.


T-cell receptor variable region usage in Chagas disease: A systematic review of experimental and human studies.

de Souza-Silva T, Gollob K, Dutra W PLoS Negl Trop Dis. 2022; 16(9):e0010546.

PMID: 36107855 PMC: 9477334. DOI: 10.1371/journal.pntd.0010546.


Oncolytic Vaccinia Virus Gene Modification and Cytokine Expression Effects on Tumor Infection, Immune Response, and Killing.

Inoue T, Byrne T, Inoue M, Tait M, Wall P, Wang A Mol Cancer Ther. 2021; 20(8):1481-1494.

PMID: 34045231 PMC: 8338778. DOI: 10.1158/1535-7163.MCT-20-0863.